Allergan's net sales rose by 23.6 percent to $606.1 million in the 3rd quarter. The growth was driven by eyewear pharmaceuticals, whose sales grew by 24.1 percent to $358.1 million in the period. The company's net profit jumped by 63.6 percent to $150.5 million.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.